Ex Cetera

Perspectives on brand identity & design, corporate branding, product branding, personal branding, brand culture, brand storytelling, ex cetera.

The pharma brand namers must be on drugs.

The pharma brand namers must be on drugs.

We all see the drug commercials on TV. It's hard to ignore the onslaught, all trying to convince us to talk to our doctor about them – even after 45 seconds of listing side effects in a 60-second spot. Thank god I'm not pregnant or nursing.

Recently I’ve seen some really bizarre brand names. Granted, this category has always been famous for them. Big pharma and their agencies have many secret formulas for brand name creation that could only appeal to chemists, medical specialists and masochists. But three new drugs are on the fringe of brand name sanity.

Farxiga, Xeljanz and Cosentyx. Wow. When commercials contain supers that show how to pronounce the name "Ask your doctor about far-SEE-guh," they’ve lost. Isn’t the rule for brand names supposed to be easy to pronounce, easy to spell and easy to remember? So what happens when you're in the doctor's office? You draw a blank. And get a prescription because you stare off into space too much. 

Pharma names are getting more and more out there – to a point where you feel like you’re looking at a Word Scramble, an eye chart or you’re in the throws of a stroke.

I need a couple of Aggrenox and Omeprazole.

blog comments powered by Disqus